Literature DB >> 19500649

Sex differences in XIAP cleavage after traumatic brain injury in the rat.

Helen M Bramlett1, Ofelia Furones-Alonso, George Lotocki, Alejandra Rodriguez-Paez, Juliana Sanchez-Molano, Robert W Keane.   

Abstract

Sex influences histological and behavioral outcomes following traumatic brain injury (TBI), but the underlying sex-dependent pathomechanisms regulating outcome measures remain poorly defined. Here, we investigated the TBI-induced regulation of the X-linked inhibitor of apoptosis protein (XIAP) that, in addition to suppressing cell death by inhibition of caspases, is involved in signaling cascades, including immune regulation and cell migration. Since estrogen has been shown to have anti-apoptotic properties, we specifically examined sex differences and the influence of estrogen on XIAP processing after TBI. Sprague-Dawley male (TBI-M), female (TBI-F), ovariectomized female (TBI-OVX) and ovariectomized females supplemented with estrogen (TBI-OVX+EST) were subjected to moderate (1.7-2.2atm) fluid percussion (FP) injury. Animals were sacrificed 24h after FP injury; cortical tissue (ipsilateral and contralateral) was dissected and analyzed for XIAP processing by immunoblot analysis (n=6-7/group) or confocal microscopy (n=2-3/group). Significant differences in XIAP cleavage products in the ipsilateral cortex were found between groups (p<0.03). Post hoc analysis showed an increase in XIAP processing in both TBI-F and TBI-OVX+EST compared to TBI-M and TBI-OVX (p<0.05), indicating that more XIAP is cleaved following injury in intact females and TBI-OVX+EST than in TBI-M and TBI-OVX groups. Co-localization of XIAP within neurons also demonstrated sex-dependent changes. Based on these data, it appears that the processing of XIAP after injury is different between males and females and may be influenced by exogenous estrogen treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19500649      PMCID: PMC2716731          DOI: 10.1016/j.neulet.2009.05.071

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  30 in total

1.  Apoptosis inhibition in ischemic brain by intraperitoneal PTD-BIR3-RING (XIAP).

Authors:  Yong-Feng Fan; Chuan-Zhen Lu; Jun Xie; Yan-Xin Zhao; Guo-Yuan Yang
Journal:  Neurochem Int       Date:  2005-11-15       Impact factor: 3.921

Review 2.  Brain damage, sex hormones and recovery: a new role for progesterone and estrogen?

Authors:  D G Stein
Journal:  Trends Neurosci       Date:  2001-07       Impact factor: 13.837

3.  Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases.

Authors:  Q L Deveraux; E Leo; H R Stennicke; K Welsh; G S Salvesen; J C Reed
Journal:  EMBO J       Date:  1999-10-01       Impact factor: 11.598

4.  Mechanism of XIAP-mediated inhibition of caspase-9.

Authors:  Eric N Shiozaki; Jijie Chai; Daniel J Rigotti; Stefan J Riedl; Pingwei Li; Srinivasa M Srinivasula; Emad S Alnemri; Robert Fairman; Yigong Shi
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

5.  Direct inhibition of caspase 3 is dispensable for the anti-apoptotic activity of XIAP.

Authors:  J Silke; P G Ekert; C L Day; C J Hawkins; M Baca; J Chew; M Pakusch; A M Verhagen; D L Vaux
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

6.  XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs.

Authors:  Fiona L Scott; Jean-Bernard Denault; Stefan J Riedl; Hwain Shin; Martin Renatus; Guy S Salvesen
Journal:  EMBO J       Date:  2005-01-13       Impact factor: 11.598

7.  Apoptotic and antiapoptotic mechanisms after traumatic brain injury.

Authors:  R W Keane; S Kraydieh; G Lotocki; O F Alonso; P Aldana; W D Dietrich
Journal:  J Cereb Blood Flow Metab       Date:  2001-10       Impact factor: 6.200

8.  Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury.

Authors:  Juan Pablo de Rivero Vaccari; George Lotocki; Ofelia F Alonso; Helen M Bramlett; W Dalton Dietrich; Robert W Keane
Journal:  J Cereb Blood Flow Metab       Date:  2009-04-29       Impact factor: 6.200

9.  17beta-Estradiol extends ischemic thresholds and exerts neuroprotective effects in cerebral subcortex against transient focal cerebral ischemia in rats.

Authors:  Tao Fan; Shao-Hua Yang; Erik Johnson; Barbara Osteen; Ronald Hayes; Arthur L Day; James W Simpkins
Journal:  Brain Res       Date:  2003-12-12       Impact factor: 3.252

Review 10.  Bench-to-bedside review: Apoptosis/programmed cell death triggered by traumatic brain injury.

Authors:  Xiaopeng Zhang; Yaming Chen; Larry W Jenkins; Patrick M Kochanek; Robert S B Clark
Journal:  Crit Care       Date:  2004-09-03       Impact factor: 9.097

View more
  5 in total

1.  Sex Differences in Traumatic Brain Injury: What We Know and What We Should Know.

Authors:  Raeesa Gupte; William Brooks; Rachel Vukas; Janet Pierce; Janna Harris
Journal:  J Neurotrauma       Date:  2019-07-19       Impact factor: 5.269

2.  X-linked inhibitor of apoptosis inhibits apoptosis and preserves the blood-brain barrier after experimental subarachnoid hemorrhage.

Authors:  Cheng Gao; Hongwei Yu; Cong Yan; Wenyang Zhao; Yao Liu; Dongdong Zhang; Jingwei Li; Nan Liu
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

Review 3.  Sex Differences in Animal Models of Traumatic Brain Injury.

Authors:  Todd G Rubin; Michael L Lipton
Journal:  J Exp Neurosci       Date:  2019-05-13

4.  Anti-edema effect of Aloe vera leaf extract following traumatic brain injury: Role of pro-inflammatory cytokines.

Authors:  Marzieh Shahryari; Bahram Bibak; Mohammad Khaksari; Zakieh Keshavarzi; Neda Salmani; Sara Shirazpour; Fatemeh Alimahdi
Journal:  Avicenna J Phytomed       Date:  2021 Jul-Aug

Review 5.  Therapeutic hypothermia and targeted temperature management for traumatic brain injury: Experimental and clinical experience.

Authors:  W Dalton Dietrich; Helen M Bramlett
Journal:  Brain Circ       Date:  2017-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.